BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33767579)

  • 1. Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis.
    Liu D; Vadgama J; Wu Y
    Int J Biol Sci; 2021; 17(3):670-682. PubMed ID: 33767579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.
    Li CI; Zhang Y; Cieślik M; Wu YM; Xiao L; Cobain E; Tang MC; Cao X; Porter P; Guenthoer J; Robinson DR; Chinnaiyan AM
    Clin Cancer Res; 2021 Jun; 27(11):3079-3093. PubMed ID: 33753452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.
    Hachim IY; Villatoro M; Canaff L; Hachim MY; Boudreault J; Haiub H; Ali S; Lebrun JJ
    Sci Rep; 2017 Nov; 7(1):14976. PubMed ID: 29101386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
    Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
    Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
    [No Abstract]   [Full Text] [Related]  

  • 5. Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer.
    Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Nagahashi M; Takabe K
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2.
    Hubackova S; Kucerova A; Michlits G; Kyjacova L; Reinis M; Korolov O; Bartek J; Hodny Z
    Oncogene; 2016 Mar; 35(10):1236-49. PubMed ID: 25982278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
    Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
    J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
    Shepherd JH; Uray IP; Mazumdar A; Tsimelzon A; Savage M; Hilsenbeck SG; Brown PH
    Oncotarget; 2016 Mar; 7(11):13106-21. PubMed ID: 26894864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer.
    Wu L; Zhang Y; Zheng C; Zhao F; Lin Y
    BMC Womens Health; 2023 Jul; 23(1):396. PubMed ID: 37507701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands.
    Karasar P; Esendagli G
    Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and evaluation of network modules for the prognosis of basal-like breast cancer.
    Hallett RM; Cockburn JG; Li B; Dvorkin-Gheva A; Hassell JA; Bane A
    Oncotarget; 2015 Jul; 6(19):17713-24. PubMed ID: 25991675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFβ and IL10 have an impact on risk group and prognosis in childhood ALL.
    Winkler B; Taschik J; Haubitz I; Eyrich M; Schlegel PG; Wiegering V
    Pediatr Blood Cancer; 2015 Jan; 62(1):72-9. PubMed ID: 25263239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
    She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
    BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-cadherin and vimentin are useful basal markers in breast cancers.
    Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
    Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-induced gene TGFBI is correlated with the prognosis and immune infiltrations of breast cancer.
    Wang H; Wang X; Xu L
    World J Surg Oncol; 2024 Jan; 22(1):22. PubMed ID: 38245723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IFN-induced 2'-5'-oligoadenylate synthetases correlates with immune infiltration, revealing potential targets and new biomarkers for basal-like breast cancer prognosis.
    Zhao J; Zhang X; Cheng M; Guan J; Gai J; Fu L; Zhang R; Du T; Li Q
    Int Immunopharmacol; 2020 Nov; 88():106916. PubMed ID: 32882665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
    Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models
    Yang Y; Yang HH; Tang B; Wu AML; Flanders KC; Moshkovich N; Weinberg DS; Welsh MA; Weng J; Ochoa HJ; Hu TY; Herrmann MA; Chen J; Edmondson EF; Simpson RM; Liu F; Liu H; Lee MP; Wakefield LM
    Clin Cancer Res; 2020 Feb; 26(3):643-656. PubMed ID: 31582516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
    de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
    Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.